艾瑞製藥ARRY

那斯達克 · USD
6.81
-0.33
(-4.62%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 3.50
  • 3.42
  • 1.53
  • 2.56
  • 2.31
  • 2.75
  • 3.02
  • 3.62
  • 3.93
  • 2.26
icon
  • -30.98
  • -2.52
  • -55.09
  • 66.73
  • -9.52
  • 18.94
  • 9.86
  • 19.80
  • 8.63
  • -42.55
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
226,044
393,491
362,243
302,363
275,232
231,406
255,766
153,403
341,615
350,438
營業成本
206,714287,820265,119225,935196,913153,091169,81398,313257,386263,058
營業毛利
19,330
105,671
97,124
76,428
78,319
78,315
85,953
55,090
84,229
87,380
營業費用
167,43660,22050,74849,144220,665210,99046,35146,67654,00947,175
研發費用
----------
推銷及管理費用
56,62853,26245,10443,79546,05940,11037,47437,04944,44237,622
非經常性項目費用
102,560---165,904162,000----
其他營業費用
8,2486,9585,6445,3498,7028,8808,8779,6279,5679,553
營業利益
-46,383
45,451
46,376
27,284
-142,346
-132,675
39,602
8,414
30,220
40,205
其他收入及費用
7683,03919,2714,0311,3043,4352,5203,9959922,046
利息費用
5,4825,0468,7688,0359,0078,2648,6148,9408,85713,064
稅前純益
-152,820
43,444
56,879
23,280
-150,049
-137,504
33,508
3,469
22,355
29,187
所得稅
-7,0749,94113,6176,534-23,1463,8507,8101,3043,0139,833
稅後純益
-145,746
33,503
43,262
16,746
-126,903
-141,354
25,698
2,165
19,342
19,354
基本每股稅後盈餘(元)
-1.060.120.190.02-0.93-1.020.08-0.070.040.07
稀釋每股稅後盈餘(元)
-1.050.120.180.02-0.93-1.020.07-0.070.040.06
基本平均股數(千股)
152752.00152727.00152584.00152076.00151944.00151923.00151797.00151351.00151175.00151068.00
稀釋平均股數(千股)
152752.00154090.00153068.00152783.00151944.00151923.00152207.00151351.00152110.00152323.00
還原基本每股稅後盈餘(元)
-1.060.120.190.02-0.93-1.020.08-0.070.040.07
還原稀釋每股稅後盈餘(元)
-1.050.120.180.02-0.93-1.020.07-0.070.040.06
還原基本平均股數(千股)
152,752152,727152,584152,076151,944151,923151,797151,351151,175151,068
還原稀釋平均股數(千股)
152,752154,090153,068152,783151,944151,923152,207151,351152,110152,323
EBITDA(千元)
-130,87761,60977,49442,392-126,761-114,49156,64127,72646,24959,920

大家都在看

HOT